NCT00197873View on ClinicalTrials.gov

Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Colorectal Cancer
Interventions
DIETARY_SUPPLEMENT

Lactobacillus Rhamnosus supplementation

Lactophilus supplementation is administered during chemotherapy.

OTHER

Placebo administration.

Placebo is administered during chemotherapy.

Trial Locations (1)

FIN-00029

Department of Oncology, Helsinki

All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

lead

University of Helsinki

OTHER

NCT00197873 - Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea | Biotech Hunter | Biotech Hunter